BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

  EUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine.

  February 3, 2022

   · 

  3 min read
• BioCapital

  Incyte to Present at Upcoming Investor Conference - Feb 03, 2022

  Incyte announced that it will present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 11:20 a.m. ET.

  February 3, 2022

   · 

  1 min read
• Bio NC

  Worldwide Clinical Trials and Ledger Run Partner to Optimize Clinical Research Business Operations

  Worldwide Clinical Trials, Inc., the industry’s leading global, midsize, full-service contract research organization, announced its partnership with Ledger Run, Inc., an innovative technology company.

  February 3, 2022

   · 

  3 min read
• Business

  Curie Therapeutics Appoints Kapil Dhingra, MBBS, to Board of Directors

  Curie Therapeutics Inc. today announced the appointment of Kapil Dhingra, MBBS, to its Board of Directors.

  February 3, 2022

   · 

  3 min read
• Business

  Charles River Laboratories Announces Wind Contract with Repsol for European Operations

  Charles River Laboratories International, Inc. (NYSE: CRL) today announced a wind energy contract with Repsol to address the entirety of the Company’s European power requirements with renewable energy by 2023.

  February 3, 2022

   · 

  4 min read
• Genetown

  Nimbus Therapeutics Shares Update on Discovery Efforts in Computational Chemistry, Expands Leadership Team

  Nimbus Therapeutics today announced the successful generation of multiple, high-resolution protein structures of Werner syndrome helicase (WRN).

  February 3, 2022

   · 

  3 min read
• Drug Development

  Synthekine Doses First Patient in Phase 1 Clinical Trial of IL-2 Partial Agonist, STK-012, for Treatment of Solid Tumors

  Synthekine Inc. , an engineered cytokine therapeutics company, today announced the dosing of the first patient in a Phase 1a/1b clinical trial of its IL-2 partial agonist, STK-012.

  February 3, 2022

   · 

  2 min read
• Business

  Emulate Announces Promotion of Dr. Lorna Ewart to Chief Scientific Officer

  Emulate, Inc., a leading provider of next-generation in vitro models, today announced the promotion of Lorna Ewart, PhD, to Chief Scientific Officer.

  February 3, 2022

   · 

  3 min read
• Business

  Moderna to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022

  Moderna, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 24, 2022 to report its fourth quarter and full year 2021 financial results, and provide a corporate update.

  February 3, 2022

   · 

  2 min read
• Business

  EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

  EVERSANA today announced a strategic partnership with Integra Connect, LLC to create a comprehensive longitudinal oncology patient database.

  February 3, 2022

   · 

  4 min read